PAUL HILL: Open Payments
NPI 1740283910 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 23 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| ARGENX US, INC. | 4 | $78 |
| ACADIA Pharmaceuticals Inc | 2 | $52 |
| EMD Serono, Inc. | 2 | $33 |
| TG Therapeutics, Inc. | 1 | $29 |
| Biogen, Inc. | 1 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
Products named: KESIMPTA, VYVGART HYTRULO, NUPLAZID, BRIUMVI, VUMERITY, Xeomin, REXULTI, VALTOCO.
Industry payments across TN — which companies pay providers there.
